The present invention relates to the use of neutral endopeptidase inhibitors (NEPi) and a combination of NEPi and phosphodiesterase type 5 (PDE5) inhibitor for the treatment of male sexual dysfunction, in particular MED.

 
Web www.patentalert.com

< CETP inhibitors

< Estrogen receptor modulators

> Synergistic conjugated linoleic acid (CLA) and carnitine combination

> Process for producing paroxetine hydrochloride hydrate
~ 00241